Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Desensitization to imatinib in patients with leukemia.
Nelson RP Jr, Cornetta K, Ward KE, Ramanuja S, Fausel C, Cripe LD. Nelson RP Jr, et al. Among authors: fausel c. Ann Allergy Asthma Immunol. 2006 Aug;97(2):216-22. doi: 10.1016/S1081-1206(10)60016-6. Ann Allergy Asthma Immunol. 2006. PMID: 16937754
Final report of toxicity and efficacy of a phase II study of oral cyclophosphamide, thalidomide, and prednisone for patients with relapsed or refractory multiple myeloma: A Hoosier Oncology Group Trial, HEM01-21.
Suvannasankha A, Fausel C, Juliar BE, Yiannoutsos CT, Fisher WB, Ansari RH, Wood LL, Smith GG, Cripe LD, Abonour R. Suvannasankha A, et al. Among authors: fausel c. Oncologist. 2007 Jan;12(1):99-106. doi: 10.1634/theoncologist.12-1-99. Oncologist. 2007. PMID: 17227904 Free article. Clinical Trial.
Leukemia. Q&A highlights.
Frame D, Sessions J, Fausel C. Frame D, et al. Among authors: fausel c. Am J Health Syst Pharm. 2007 Dec 15;64(24 Suppl 15):S22. doi: 10.2146/ajhp070503. Am J Health Syst Pharm. 2007. PMID: 18056929 No abstract available.
Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia.
Nelson RP Jr, Yu M, Schwartz JE, Robertson MJ, Hromas R, Fausel CA, Vance GH, Dlouhy SR, Baute JA, Cox EA, Wood LL, Srivastava S, Robertson KA, Haut PR, Farag SS, Abonour R, Cornetta K, Cripe LD. Nelson RP Jr, et al. Among authors: fausel ca. Bone Marrow Transplant. 2010 Aug;45(8):1300-8. doi: 10.1038/bmt.2009.348. Epub 2010 Jan 11. Bone Marrow Transplant. 2010. PMID: 20062092
Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
Rosenbeck LL, Kiel PJ, Kalsekar I, Vargo C, Baute J, Sullivan CK, Wood L, Abdelqader S, Schwartz J, Srivastava S, Abonour R, Robertson MJ, Nelson RP Jr, Cornetta K, Fausel CA, Farag SS. Rosenbeck LL, et al. Among authors: fausel ca. Biol Blood Marrow Transplant. 2011 Jun;17(6):916-22. doi: 10.1016/j.bbmt.2010.09.017. Epub 2010 Dec 4. Biol Blood Marrow Transplant. 2011. PMID: 20932925 Free article.
29 results